Owlstone Medical Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
169
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$31.4M
- Investors
-
12
Owlstone Medical General Information
Description
Developer of a healthcare breathalyzer product designed to focus on non-invasive diagnostics for the early detection of disease and on precision medicine. The company is developing a biopsy product and a proprietary sample collection device that can take stable breath samples anywhere, enabling doctors to avail detection of diseases, including lung cancer, liver disease, digestive health, and respiratory disease.
Contact Information
Website
www.owlstonemedical.comCorporate Office
- 183 Cambridge Science Park
- Milton Road
- Cambridge CB4 0GJ
- England, United Kingdom
Corporate Office
- 183 Cambridge Science Park
- Milton Road
- Cambridge CB4 0GJ
- England, United Kingdom
Owlstone Medical Timeline
Owlstone Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series E) | 25-Mar-2025 | $31.4M | Completed | Clinical Trials - Phase 2 | ||
| 11. Grant | 25-Feb-2024 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC | 25-Feb-2024 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC (Series D) | 31-Aug-2021 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC | 01-Oct-2018 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 25-Jan-2018 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 27-Mar-2017 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 06-Jan-2017 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 11-Dec-2016 | $1.38M | $9.3M | Completed | Clinical Trials - Phase 2 | |
| 3. Later Stage VC | 28-Jun-2016 | $7.27M | $9.3M | Completed | Clinical Trials - Phase 2 |
Owlstone Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Convertible E | ||||||||
| Convertible E | ||||||||
| Convertible E | ||||||||
| Convertible E | ||||||||
| Convertible E | ||||||||
| A Ordinary | ||||||||
| D Ordinary | ||||||||
| A Ordinary | ||||||||
| C Ordinary | 23,667 | $0.000128 | $16.75 | $16.75 | 1x | $16.75 | 0.15% | |
| C Ordinary | 1,230,770 | $0.000128 | $17.19 | $17.19 | 1x | $17.19 | 7.77% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Owlstone Medical Comparisons
Industry
Financing
Details
Owlstone Medical Competitors (5)
One of Owlstone Medical’s 5 competitors is Breath Diagnostics, a Venture Capital-Backed company based in Louisville, KY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Breath Diagnostics | Venture Capital-Backed | Louisville, KY | ||||
| Breathe BioMedical | Venture Capital-Backed | Moncton, Canada | ||||
| HemoCue | Corporate Backed or Acquired | Ängelholm, Sweden | ||||
| COSMED | Venture Capital-Backed | Rome, Italy | ||||
| Natus Medical | Private Equity-Backed | Middleton, WI |
Owlstone Medical Patents
Owlstone Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202417686-D0 | Breath sampling device | Pending | 02-Dec-2024 | ||
| WO-2026120265-A1 | Breath sampling device | Pending | 02-Dec-2024 | ||
| GB-202407301-D0 | Diagnosis of liver disease | Inactive | 22-May-2024 | ||
| WO-2025243037-A1 | Diagnosis of liver disease | Pending | 22-May-2024 | ||
| GB-202404341-D0 | Breath analysis device | Pending | 26-Mar-2024 | G01N33/497 |
Owlstone Medical Signals
Owlstone Medical Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cystic Fibrosis Foundation | Limited Partner | Minority | ||
| HSBC Global Custody Nominee (UK) | Other | Minority | ||
| Gates Foundation | Not-For-Profit Venture Capital | Minority | ||
| Hon Hai Precision Industry | Corporation | Minority | ||
| Horizons Ventures | Venture Capital | Minority |
Owlstone Medical FAQs
-
When was Owlstone Medical founded?
Owlstone Medical was founded in 2003.
-
Where is Owlstone Medical headquartered?
Owlstone Medical is headquartered in Cambridge, United Kingdom.
-
What is the size of Owlstone Medical?
Owlstone Medical has 169 total employees.
-
What industry is Owlstone Medical in?
Owlstone Medical’s primary industry is Diagnostic Equipment.
-
Is Owlstone Medical a private or public company?
Owlstone Medical is a Private company.
-
What is the current valuation of Owlstone Medical?
The current valuation of Owlstone Medical is .
-
What is Owlstone Medical’s current revenue?
The current revenue for Owlstone Medical is .
-
How much funding has Owlstone Medical raised over time?
Owlstone Medical has raised $213M.
-
Who are Owlstone Medical’s investors?
Cystic Fibrosis Foundation, HSBC Global Custody Nominee (UK), Gates Foundation, Hon Hai Precision Industry, and Horizons Ventures are 5 of 12 investors who have invested in Owlstone Medical.
-
Who are Owlstone Medical’s competitors?
Breath Diagnostics, Breathe BioMedical, HemoCue, COSMED, and Natus Medical are competitors of Owlstone Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process